Currently there are no FDA cleared echocardiography contrast agents commercially available for use on the right side of the heart to detect shunts, but a new agent that promises to improve workflow and imaging is about to enter a U.S. trial. 

ACC President Christopher Kramer, MD, testified before a Congressional subcommittee to ask for federal funding to support a new law aimed at reducing sudden cardiac arrest deaths, and to support NIH research.

Researchers at Oregon State University are working on developing a way to make contrast agents more targeted. 

The late-breaking five-year results of the Evolut Low-Risk Trial presented at ACC.25 showed positive results for the Evolut TAVR system when compared to SAVR.

Paul Rodrigue, MD, went missing last week and was last seen on Saturday, March 29, in the Mid-City area.

UPDATED: Amid criticism from the business community, the White House on Wednesday scaled back some of its proposal. 

Common drivers include performing an unsafe number of studies, lack of administrative support and pressure to conduct unnecessary imaging.    
 

Imaging experts speculated that the COVID-19 pandemic and other factors may be helping to improve gender disparities across the profession. 

Affidea is one of the largest radiology providers in Europe, operating a network of 391 centers spanning 15 countries and handling 20 million scans annually. 

Some AI decision-support models have a proclivity for recommending aggressive care pathways. And doing so on the basis of patient demographics, not medical necessity.